All Stories

  1. Analysis of the shear stresses in a filling line of parenteral products: The role of sterilizing filters
  2. Chondroitin sulfate and caseinophosphopeptides doped polyurethane-based highly porous 3D scaffolds for tendon-to-bone regeneration
  3. Shear stress as a driver of degradation for protein-based therapeutics: More accomplice than culprit
  4. Advances in Ascorbic Acid (Vitamin C) Manufacturing: Green Extraction Techniques from Natural Sources
  5. The Freeze-Drying of Pharmaceuticals in Vials Nested in a Rack System—Part II: Primary Drying Behaviour
  6. Tailoring Dry Microparticles for Pulmonary Drug Delivery: Ultrasonic Spray Freeze-Drying with Mannitol and Salbutamol Sulphate
  7. Comparative Studies of Different Preservation Methods and Relative Freeze-Drying Formulations for Extracellular Vesicle Pharmaceutical Applications
  8. New Trends in Freeze-Drying of Pharmaceutical Products
  9. Thermodynamic Modeling and Experimental Data Reveal That Sugars Stabilize Proteins According to an Excluded Volume Mechanism
  10. Mechanistic Investigation of tert-Butanol’s Impact on Biopharmaceutical Formulations: When Experiments Meet Molecular Dynamics
  11. A diffused-interface model for the lyophilization of a packed bed of spray-frozen particles
  12. Analysis of the Shear Stresses in a Filling Line of Parenteral Products: The Role of Fittings
  13. Self-Assembled Monolayers As a Tool to Investigate the Effect of Surface Chemistry on Protein Nucleation
  14. Analysis of the Shear Stresses in a Filling Line of Parenteral Products: The Role of Tubing
  15. On the Use of Temperature Measurements as a Process Analytical Technology (PAT) for the Monitoring of a Pharmaceutical Freeze-Drying Process
  16. Freeze-Drying of Pharmaceuticals in Vials Nested in a Rack System—Part I: Freezing Behaviour
  17. Modernizing Manufacturing of Parenteral Products
  18. Cytotoxicity and Thermal Characterization Assessment of Excipients for the Development of Innovative Lyophilized Formulations for Oncological Applications
  19. A New Transfer Free Energy Based Implicit Solvation Model for the Description of Disordered and Folded Proteins
  20. An Experimental and Modeling Combined Approach in Preparative Hydrophobic Interaction Chromatography
  21. Combining Mathematical Modeling and Thermal Infrared Data in the Freezing of Pharmaceutical Liquid Formulations
  22. Ultrasonic spray freeze-drying of sucrose and mannitol-based formulations: Impact of the atomization conditions on the particle morphology and drying performance
  23. Lipid-Based Nanovesicular Drug Delivery Systems
  24. Use of Microfluidic Capillary Electrophoresis for the Determination of Multi-Component Protein Adsorption Isotherms: Application to High-Throughput Analysis for Hydrophobic Interaction Chromatography
  25. Surface Treatment of Glass Vials for Lyophilization: Implications for Vacuum-Induced Surface Freezing
  26. Investigation of the Freezing Phenomenon in Vials Using an Infrared Camera
  27. Alginate Nanohydrogels as a Biocompatible Platform for the Controlled Release of a Hydrophilic Herbicide
  28. Effect of Polymerization Time on the Binding Properties of Ciprofloxacin-Imprinted nanoMIPs Prepared by Solid-Phase Synthesis
  29. Force Field Parameterization for the Description of the Interactions between Hydroxypropyl-β-Cyclodextrin and Proteins
  30. In-Line Monitoring of the Freeze-Drying Process by Means of Heat Flux Sensors
  31. The Role of Cyclodextrins against Interface-Induced Denaturation in Pharmaceutical Formulations: A Molecular Dynamics Approach
  32. Tuning Transport Phenomena in Agarose Gels for the Control of Protein Nucleation Density and Crystal Form
  33. Role of Self-Assembled Surface Functionalization on Nucleation Kinetics and Oriented Crystallization of a Small-Molecule Drug: Batch and Thin-Film Growth of Aspirin as a Case Study
  34. Enhancing the preservation of liposomes: The role of cryoprotectants, lipid formulations and freezing approaches
  35. Economic Analysis of a Freeze-Drying Cycle
  36. ADD Force Field for Sugars and Polyols: Predicting the Additivity of Protein–Osmolyte Interaction
  37. Agarose Gel as a Medium for Growing and Tailoring Protein Crystals
  38. General and adaptive synthesis protocol for high-quality organosilane self-assembled monolayers as tunable surface chemistry platforms for biochemical applications
  39. Spray Freeze-Drying as a Solution to Continuous Manufacturing of Pharmaceutical Products in Bulk
  40. Automatic control of a freeze-drying process: Detection of the end point of primary drying
  41. A model-based approach for the rational design of the freeze-thawing of a protein-based formulation
  42. Heightened Cold-Denaturation of Proteins at the Ice–Water Interface
  43. Impact of Controlled Vacuum Induced Surface Freezing on the Freeze Drying of Human Plasma
  44. Synthesis of high payload nanohydrogels for the ecapsulation of hydrophilic molecules via inverse miniemulsion polymerization: caffeine as a case study
  45. From Batch to Continuous: Freeze-Drying of Suspended Vials for Pharmaceuticals in Unit-Doses
  46. Tuning, measurement and prediction of the impact of freezing on product morphology: A step toward improved design of freeze-drying cycles
  47. Supporting data and methods for the multi-scale modelling of freeze-drying of microparticles in packed-beds
  48. A multi-scale computational framework for modeling the freeze-drying of microparticles in packed-beds
  49. Process intensification and process control in freeze-drying
  50. Effect of Surfactants on Surface-Induced Denaturation of Proteins: Evidence of an Orientation-Dependent Mechanism
  51. Looking inside the ‘black box’: Freezing engineering to ensure the quality of freeze-dried biopharmaceuticals
  52. Surface-induced crystallization of pharmaceuticals and biopharmaceuticals: A review
  53. Surfactants as stabilizers for biopharmaceuticals: An insight into the molecular mechanisms for inhibition of protein aggregation
  54. Vacuum Induced Surface Freezing as an effective method for improved inter- and intra-vial product homogeneity
  55. The Preservation of Lyophilized Human Growth Hormone Activity: how Do Buffers and Sugars Interact?
  56. Process analytical technology for monitoring pharmaceuticals freeze-drying – A comprehensive review
  57. Measuring and predicting pore size distribution of freeze-dried solutions
  58. Water entrapment and structure ordering as protection mechanisms for protein structural preservation
  59. Clarifying the role of cryo- and lyo-protectants in the biopreservation of proteins
  60. Inclusion complexes dispersed in polystyrene-based labels for fruit ripening on demand
  61. Stability of Proteins in Carbohydrates and Other Additives during Freezing: The Human Growth Hormone as a Case Study
  62. Prediction of product morphology of lyophilized drugs in the case of Vacuum Induced Surface Freezing
  63. Prediction of Ice Crystal Size Distribution after Freezing of Pharmaceutical Solutions
  64. Impact of vacuum-induced surface freezing on inter- and intra-vial heterogeneity
  65. Non-Invasive Temperature Monitoring in Freeze Drying: Control of Freezing as a Case Study
  66. Wavelet image decomposition for characterization of freeze-dried pharmaceutical product structures
  67. Effect of Electron Beam Irradiation on Remaining Activity of Lyophilized Acid Phosphatase with Water-Binding and Non-Water–Binding Additives
  68. Vacuum-Induced Nucleation as a Method for Freeze-Drying Cycle Optimization
  69. Tailoring of Bone Scaffold Properties Using Silicate/Phosphate Glass Mixtures
  70. A New Method Based on the Regression of Step Response Data for Monitoring a Freeze-Drying Cycle
  71. Characterization of freeze-dried pharmaceutical product structures by an FFT-imaging approach
  72. Real-time temperature monitoring in pharmaceutical freeze-drying
  73. Sputtered thermocouple array for vial temperature mapping
  74. Applying quality-by-design to develop a coffee freeze-drying process
  75. Intensification of Freeze‐Drying for the Pharmaceutical and Food Industries
  76. Freeze-drying of enzymes in case of water-binding and non-water-binding substrates
  77. Quality by Design: Scale-Up of Freeze-Drying Cycles in Pharmaceutical Industry
  78. In-Line and Off-Line Optimization of Freeze-Drying Cycles for Pharmaceutical Products
  79. Quality by design: optimization of a freeze-drying cycle via design space in case of heterogeneous drying behavior and influence of the freezing protocol
  80. Model-Based Framework for the Analysis of Failure Consequences in a Freeze-Drying Process
  81. Quality by Design in the Secondary Drying Step of a Freeze-Drying Process
  82. A Model-Based Framework to Optimize Pharmaceuticals Freeze Drying
  83. Innovation in Monitoring Food Freeze Drying
  84. Advanced approach to build the design space for the primary drying of a pharmaceutical freeze‐drying process
  85. Heat Transfer in Freeze-Drying Apparatus
  86. Freeze-Drying Cycle Optimization Using Model Predictive Control Techniques
  87. Monitoring of the Secondary Drying in Freeze-Drying of Pharmaceuticals
  88. On the Methods Based on the Pressure Rise Test for Monitoring a Freeze-Drying Process
  89. In-Line Optimization and Control of an Industrial Freeze-Drying Process for Pharmaceuticals
  90. Model-Based Monitoring and Control of Industrial Freeze-Drying Processes: Effect of Batch Nonuniformity
  91. In-line control of the lyophilization process. A gentle PAT approach using software sensors
  92. Freeze Drying of Pharmaceutical Excipients Close to Collapse Temperature: Influence of the Process Conditions on Process Time and Product Quality
  93. On the Design of an In-Line Control System for a Vial Freeze-Drying Process: The Role of Chamber Pressure
  94. Monitoring of the primary drying of a lyophilization process in vials
  95. Observer design for the Selective Catalytic Reduction of NOx in a loop reactor